NCT06737952Not yet recruiting
Cellular and Molecular Analysis of Synovial Tissue of Patients With Arthritis
Source: ClinicalTrials.gov · Last updated 11 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to study the inflammatory response in various forms of arthritis.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 90 (estimated)
- First submitted
- 11 Dec 2024
- Start date
- May 2025
- Primary completion date
- Dec 2029
- Lead sponsor
- University Hospital, Basel, Switzerland
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT06737952
What you commit to
- Study type: Observational
- Planned participants: 90
- From May 2025 to the primary completion date, Dec 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known allergies to local anesthetics
Lab values
- Family history of bleeding, history of increased bleeding tendency or prolonged bleeding, current treatment with oral anticoagulants or platelet aggregation inhibitors; Quick \< 65%, international normalised ratio (INR) ≥ 1.3, thrombocyte count \< 100'000/μl, activated partial thromboplastin time (aPTT) \> 37 sec
Other
- Inability or insufficient knowledge of project language to understand the information given in the informed consent form
Who the study is looking for
- Age \>18 years
- Clinically relevant arthritis in one or more joints as assessed by the treating rheumatologist, including RA, SpA, connective tissue disease and OA.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.